Trials / Recruiting
RecruitingNCT05482906
Common and Specific Information From Neuroimaging and Smartphone
Individual Gait Pattern and MRI Lesion Load to Quantify Gait Impairment in MS: A Cross Sectional Study.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).
Detailed description
This device consists in a commercialized IMU sensor (MetaMotionR Sensor, Mbientilab) worn at the right hip, a smartphone app and dedicated algorithm/mathematical model to extract raw sensor data and calculate individual gait pattern (IGP). This IGP consists of a curve, based on quaternion and representing the rotation recorded by the IMU during an average gait cycle. Pursue previous works conducted on (IGP to assess) gait alteration in MS by adding (to IGP) new information from MRI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | eGait | IMU sensor (as part of eGait device) worn at the hip during T25FW |
Timeline
- Start date
- 2023-04-03
- Primary completion
- 2026-04-30
- Completion
- 2026-06-30
- First posted
- 2022-08-01
- Last updated
- 2026-03-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05482906. Inclusion in this directory is not an endorsement.